Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey.

CONCLUSIONS: Innovative approaches are needed to ensure continuity in access to ASM treatment. Healthcare workers should ensure continued follow-up, either through inperson or telehealth appointments, to timely identify symptoms of anxiety and depression and act accordingly. PMID: 32920373 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32920373?dopt=Abstract

Source: Epilepsy and Behaviour - September 9, 2020 Category: Neurology Authors: Van Hees S, Siewe Fodjo JN, Wijtvliet V, Van den Bergh R, Faria de Moura Villela E, da Silva CF, Weckhuysen S, Colebunders R Tags: Epilepsy Behav Source Type: research